Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT00437905
Eligibility Criteria:
Inclusion Criteria:
* Severe intermittent claucication (Fontaine stage IIb)or limb ischemia, femoropoliteal stenosis/occlusion up to 5 cm length
Exclusion Criteria:
* Previous bypass surgery at the site of treatment,
* Previous stent placement at or immediatly adjacent to target lesion,
* History of anti-platelet-therapy intolerance or adverse reaction to heparin,
* Bleeding diathesis,
* Creatinine \> 2,5 mg/dL,
* Active bacterial infection,
* Allergy to contrast media
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00437905
Study Brief:
Protocol Section:
NCT00437905